CN101797358B - Medicinal composition containing roxatidine - Google Patents
Medicinal composition containing roxatidine Download PDFInfo
- Publication number
- CN101797358B CN101797358B CN2009102653779A CN200910265377A CN101797358B CN 101797358 B CN101797358 B CN 101797358B CN 2009102653779 A CN2009102653779 A CN 2009102653779A CN 200910265377 A CN200910265377 A CN 200910265377A CN 101797358 B CN101797358 B CN 101797358B
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- chinese medicine
- medicine
- roxatidine
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a synergistic medicinal composition containing roxatidine and traditional Chinese medicine extractives, as well as an application of the composition in the preparation of medicaments for treating gastric ulcer.
Description
The present invention relates to a kind of medicine for the treatment of gastropathy, is the compositions of being made by Chinese crude drug extract and Western medicine, is particularly suitable for the medicine as treatment gastritis, peptic ulcer gastropathy such as (containing gastric ulcer and duodenal bulbar ulcer).
Gastropathy, particularly gastritis (shallow harmony in the exterior atrophic), peptic ulcer (containing gastric ulcer and duodenal bulbar ulcer) is a kind of commonly encountered diseases, frequently-occurring disease.At present, the medicine for the treatment of these diseases is more, the curative effect of the degree of having nothing in common with each other, but generally speaking, curative effect is not ideal enough, and relapse rate is higher after the drug withdrawal, and with regard to better medicine at present commonly used: its effective percentage is below 80%, and its relapse rate is more than 36%.
Purpose of the present invention just is: invent a kind of composition medicine of being made up of Chinese medicine extract and Western medicine for the treatment of gastric ulcer, to improve the treatment curative effect and to reduce relapse rate.
The present invention realizes its purpose like this: the present composition comprises Chinese medicine extract and Western medicine, and wherein Chinese medicine extract is prepared by following method:
Chinese medicine medical material component and proportional quantity thereof, % counts with percentage ratio:
Rhizoma Alpiniae Officinarum 4, the Radix Aucklandiae 3, Os Sepiae 3, Rhizoma Curcumae 10, Amomum globosum loureiro 1,
Radix Et Rhizoma Nardostachyos 6, dried Alumen 3, Endothelium Corneum Gigeriae Galli 3, Rhizoma Coptidis 3, the Pseudobulbus Bletillae (Rhizoma Bletillae) 10,
Rhizoma Corydalis 11, Fructus Hordei Germinatus 1, Radix Aristolochiae 20, Semen Trichosanthis 2, Corium elephatis 20.
The summation of its each component is 100%.
Earlier Chinese crude drug is cleaned, press the proportional quantity metering, and the medicine village is concocted with conventional concocting method, powder is defended in pulverizing, decoct with water, and filtration, concentrated filtrate is to thick paste, drying.
Pharmaceutical composition Chinese medicine and western medicine of the present invention in addition is a roxatidine, and the weight ratio of Chinese medicine extract and Western medicine is 68: 1.
Chinese medicine extract prescription in the pharmaceutical composition of the present invention is from the embodiment 1 of CN1055015C.
Pharmaceutical composition of the present invention can be made into various peroral dosage forms, and three times on the one, each 2 grams, seriously ill person's four times a day, boiled water is taken after mixing it with water.For gastritis (shallow table or atrophic), 7 is a course of treatment, serve on 2-3 the course of treatment, and for peptic ulcer (containing gastric ulcer and bulboduodenal ulcer), be a course of treatment January, serve on 2-3 the course of treatment.Taboo: dry peppery, the raw food food such as hard of fasting.
Clinical effectiveness:
To gastric ulcer 40 examples, treat 5 courses of treatment after.Through hospital's fiber microscopy and biopsy, 18 examples of wherein fully recovering, effective 19 examples, invalid 3 examples.Average total effective rate is 92.5%, and the toxic side effect reaction is found at the end.And with the pure Chinese medicine extract or the roxatidine of Isodose, effective percentage is respectively 68% and 87%.
The treatment standard declaration: recovery from illness refers to after 2-3 the course of treatment 1 clinical symptom disappearance.Through fiber microscopy and biopsy, foci disappearance.Effectively refer to after 2～8 courses of treatment, through fiber microscopy and biopsy, clinical symptom disappearance, the lesion tissue scope is dwindled.Invalid finger is after 2-3 the course of treatment, and clinical symptoms does not have significant change before fiber microscopy and biopsy and treatment.
Pharmacology and resultant effect analysis.The Rhizoma Curcumae heat-clearing and toxic substances removing of this medicine with the same usefulness of Rhizoma Coptidis, strengthens heat-clearing toxin-expelling functions, Corium elephatis granulation promoting good medicine, and dried Alumen is held back skin ulcer, reuses poliosis, the same usefulness of three flavors, granulation promoting power is grand, and it is remarkable to hold back skin ulcer, promotes the lesion tissue reparation effectively, and well can end digestive tract hemorrhage preferably; Semen Trichosanthis a surname spleen helps circulation of qi promoting intestinal stasis relieving class efficacy of drugs such as Radix Et Rhizoma Nardostachyos more remarkable, has effectively promoted the recovery of gastric motility function, reuses Rhizoma Corydalis, Radix Aristolochiae, fast and effeciently pain relieving.Therefore, comprehensive compatibility, this Chinese patent medicine is heat-clearing and toxic substances removing effectively, and effectively gastric acid inhibitory secretion of roxatidine.The Chinese medicine and western medicine binding energy fundamentally reaches therapeutic purposes.
Claims (2)
1. compositions for the treatment of gastric ulcer, said composition comprises Chinese medicine extract and Western medicine, and wherein Chinese medicine extract is prepared by following method:
Chinese medicine medical material component and proportional quantity thereof, count with percentage ratio:
Rhizoma Alpiniae Officinarum 4, the Radix Aucklandiae 3, Os Sepiae 3, Rhizoma Curcumae 10, Amomum globosum loureiro 1,
Radix Et Rhizoma Nardostachyos 6, dried Alumen 3, Endothelium Corneum Gigeriae Galli 3, Rhizoma Coptidis 3, the Pseudobulbus Bletillae (Rhizoma Bletillae) 10,
Rhizoma Corydalis 11, Fructus Hordei Germinatus 1, Radix Aristolochiae 20, Semen Trichosanthis 2, Corium elephatis 20,
The summation of its each component is 100%,
Earlier Chinese crude drug is cleaned, press the proportional quantity metering, and medical material is concocted with conventional concocting method, be ground into powder, decoct with water, filtration, concentrated filtrate is to thick paste, drying;
Western medicine is a roxatidine, and the weight ratio of Chinese medicine extract and Western medicine is 68: 1.
2. the purposes of compositions as claimed in claim 1 in the medicine of preparation treatment gastric ulcer.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102653779A CN101797358B (en) | 2009-12-30 | 2009-12-30 | Medicinal composition containing roxatidine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102653779A CN101797358B (en) | 2009-12-30 | 2009-12-30 | Medicinal composition containing roxatidine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101797358A CN101797358A (en) | 2010-08-11 |
| CN101797358B true CN101797358B (en) | 2011-06-15 |
Family
ID=42593299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102653779A Expired - Fee Related CN101797358B (en) | 2009-12-30 | 2009-12-30 | Medicinal composition containing roxatidine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101797358B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101066434A (en) * | 2007-06-05 | 2007-11-07 | 陈旭龙 | Omeprazole-containing medicine |
| CN101066435A (en) * | 2007-06-05 | 2007-11-07 | 陈旭龙 | Iprazole containing medicine |
| CN101269200A (en) * | 2008-04-29 | 2008-09-24 | 乐亚 | Chinese-western medicine composition containing carafate for treating gastric ulcer |
-
2009
- 2009-12-30 CN CN2009102653779A patent/CN101797358B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101066434A (en) * | 2007-06-05 | 2007-11-07 | 陈旭龙 | Omeprazole-containing medicine |
| CN101066435A (en) * | 2007-06-05 | 2007-11-07 | 陈旭龙 | Iprazole containing medicine |
| CN101269200A (en) * | 2008-04-29 | 2008-09-24 | 乐亚 | Chinese-western medicine composition containing carafate for treating gastric ulcer |
Non-Patent Citations (1)
| Title |
|---|
| 金山.《"五足鼎立"抗溃疡》.《医药经济报》.2007,第003版. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101797358A (en) | 2010-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101066434B (en) | Omeprazole-containing medicine | |
| CN100584371C (en) | Chinese-western medicine composition containing carafate for treating gastric ulcer | |
| CN100515484C (en) | Iprazole containing medicine | |
| CN100534516C (en) | Medicine containing rabeprazole for treating gastric ulcer | |
| CN100515485C (en) | Medicine composition for treating gastric ulcer | |
| CN101850044B (en) | Medicament for treating peptic ulcer and reflux esophagitis and preparation method thereof | |
| CN100574793C (en) | The medicine that contains ranitidine | |
| CN101926958B (en) | Chinese and Western medicine composition containing carbenoxolone sodium | |
| CN1055015C (en) | Weijisan for gastropathy | |
| CN101066418B (en) | Medicine containing colloidal bismuth for treating gastric uncer | |
| CN101797358B (en) | Medicinal composition containing roxatidine | |
| CN101797357B (en) | Chinese-western medicinal composition containing lansoprazole | |
| CN101797359B (en) | Chinese and western medicinal composition containing pantoprazole | |
| CN101797356B (en) | Traditional Chinese medicine and Western medicine composition containing Lafutidine | |
| CN101732664B (en) | Enprostil-containing Chinese and Western medicinal composition for treating gastric ulcer | |
| CN101797364B (en) | Marzulene-s-containing combined medicine | |
| CN101721657B (en) | Chinese and western medicine composition containing licorzinc | |
| CN101773645B (en) | Chinese-western medicine composition containing spizofurone | |
| CN101810828B (en) | Combination medicament containing teprenone | |
| CN101773646B (en) | Chinese and Western medicine composition containing proglumide | |
| CN101732663B (en) | Rebamipide-containing Chinese and western medicinal composition | |
| CN1255165C (en) | Traditional Chinese medicinal preparation for treating iternal-external ulcer and its preparation method | |
| CN1270754C (en) | Gastropathy treating medicine and its preparation | |
| CN104258033A (en) | Traditional Chinese medicine preparation for treating chronic bronchitis at acute stage | |
| CN103356942B (en) | Medicine for treating chronic gastritis, gastric ulcer and/or duodenal ulcer and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| DD01 | Delivery of document by public notice |
Addressee: Qian Xin Document name: Notification of Passing Preliminary Examination of the Application for Invention |
|
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| DD01 | Delivery of document by public notice |
Addressee: Qian Xin Document name: Notification of Publication and of Entering the Substantive Examination Stage of the Application for Invention |
|
| DD01 | Delivery of document by public notice |
Addressee: Qian Xin Document name: the First Notification of an Office Action |
|
| ASS | Succession or assignment of patent right |
Owner name: LI MENG Free format text: FORMER OWNER: QIAN XIN Effective date: 20110422 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Li Meng Inventor after: Qian Xin Inventor before: Qian Xin |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 311203 NANMENJIANG UPTOWN, XIAOSHAN DISTRICT, HANGZHOU CITY, ZHEJIANG PROVINCE TO: 315104 DONGXING RESIDENTIAL QUARTER, XIAYING SUBDISTRICT, YINZHOU DISTRICT, NINGBO CITY, ZHEJIANG PROVINCE Free format text: CORRECT: INVENTOR; FROM: QIAN XIN TO: LI MENG QIAN XIN |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20110422 Address after: 315104 Dongxing District, Yinzhou District, Zhejiang, Ningbo Applicant after: Li Meng Address before: 311203, Hangzhou District, Zhejiang City, Xiaoshan Province South Gate residential area Applicant before: Qian Xin |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110615 Termination date: 20111230 |